Mitsubishi Tanabe Pharma is a pharmaceutical company that focuses on the research, development, and distribution of innovative medical solutions. With a rich history dating back to its founding in Japan, the company has established itself as a leader in the pharmaceutical industry, particularly in the areas of neurology, immunology, and diabetes care.

The company is committed to improving the quality of life for patients worldwide through its cutting-edge therapies and dedication to scientific excellence. Mitsubishi Tanabe Pharma operates globally, with a strong presence in Asia, North America, and Europe, and collaborates with various partners to enhance its research capabilities and expand its product offerings.

In terms of sustainability, Mitsubishi Tanabe Pharma has made efforts to integrate environmental, social, and governance (ESG) considerations into its business operations. The company has set targets to reduce its carbon footprint and improve energy efficiency across its facilities. It also engages in responsible sourcing practices and strives to minimize waste through recycling and other initiatives.

However, detailed information on specific sustainability certifications or accreditations is limited. The company continues to work towards enhancing its sustainability performance and transparency in reporting its progress. Mitsubishi Tanabe Pharma recognizes the importance of sustainable practices in contributing to a healthier planet and society.